English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/203674
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer

AuthorsBoloix, Ariadna; Masanas, Marc; Jiménez, Carlos; Antonelli, Roberta; Soriano, Aroa; Roma, Josep; Sánchez de Toledo, Josep; Gallego, Soledad; Segura, Miguel F.
Issue Date6-Nov-2019
AbstractIn recent decades, biomedical research has focused on understanding the functionality of the human translated genome, which represents a minor part of all genetic information transcribed from the human genome. However, researchers have become aware of the importance of non-coding RNA species that constitute the vast majority of the transcriptome. In addition to their crucial role in tissue development and homeostasis, mounting evidence shows non-coding RNA to be deregulated and functionally contributing to the development and progression of different types of human disease including cancer both in adults and children. Small non-coding RNAs (i.e., microRNA) are in the vanguard of clinical research which revealed that RNA could be used as disease biomarkers or new therapeutic targets. Furthermore, many more expectations have been raised for long non-coding RNAs, by far the largest fraction of non-coding transcripts, and still fewer findings have been translated into clinical applications. In this review, we center on PVT1, a large and complex long non-coding RNA that usually confers oncogenic properties on different tumor types. We focus on the compilation of early advances in the field of pediatric tumors which often lags behind clinical improvements in adult tumors, and provide a rationale to continue studying PVT1 as a possible functional contributor to pediatric malignancies and as a potential prognostic marker or therapeutic target.
Publisher version (URL)http://dx.doi.org/10.3389/fonc.2019.01173
URIhttp://hdl.handle.net/10261/203674
Appears in Collections:(ICMAB) Artículos
Files in This Item:
File Description SizeFormat 
Boloix_FrontOnc_2019_editorial.pdf1,09 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.